Search

Your search keyword '"Amoura, Zahir"' showing total 1,922 results

Search Constraints

Start Over You searched for: Author "Amoura, Zahir" Remove constraint Author: "Amoura, Zahir"
1,922 results on '"Amoura, Zahir"'

Search Results

1. A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications

2. Hematological features and alternate diagnoses in critically ill thrombotic antiphospholipid syndrome patients

4. French protocol for the diagnosis and management of systemic lupus erythematosus

5. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

6. Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)

9. Comparison of patients with isolated cutaneous lupus erythematosus versus systemic lupus erythematosus with cutaneous lupus erythematosus as the sole clinical feature: A monocentric study of 149 patients

16. Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies

17. Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome

18. Rationale and design of the ARAMIS trial: Anakinra versus placebo, a double blind randomized controlled trial for the treatment of acute myocarditis

21. Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial

22. Clinical phenotype of adult-onset systemic histiocytosis harboring BRAF in-frame deletions

23. Ophthalmic vascular manifestations in eosinophil-associated diseases: a comprehensive analysis of 57 patients from the CEREO and EESG networks and a literature review

25. Intravenous Immunoglobulins Tapering and Withdrawal in Systemic Capillary Leak Syndrome (Clarkson Disease)

26. Phenotypic Heterogeneity of Fulminant COVID-19--Related Myocarditis in Adults

28. Cardiac adipose tissue volume assessed by computed tomography is a specific and independent predictor of early mortality and critical illness in COVID-19 in type 2-diabetic patients

29. French protocol for the diagnosis and management of systemic lupus erythematosus.

30. LBP2 Development and validation of a patient-centered autoevaluation questionnaire in systemic lupus erythematosus: LUPIN

31. Comparison of patients with isolated cutaneous erythematosus (CLE) versus SLE with CLE as the sole clinical feature: a monocentric study of 149 patients

32. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

33. High frequency of clonal hematopoiesis in Erdheim-Chester disease

37. Neurological diseases of unknown etiology: Brain-biopsy diagnostic yields and safety

38. The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET

39. Health-related quality of life, remission and low lupus disease activity state in patients with systemic lupus erythematosus.

40. Higher Levels of SARS-CoV-2 Genetic Variation in Immunocompromised Patients: A Retrospective Case-Control Study.

42. Publisher Correction: The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET

44. In-Hospital Mortality-Associated Factors in Patients With Thrombotic Antiphospholipid Syndrome Requiring ICU Admission

46. Epidemiology and geographic clustering of Erdheim-Chester disease in Italy and France

47. Low plasma belimumab levels as an indicator of poor adherence to belimumab in patients with systemic lupus erythematosus

48. Higher levels of SARS-CoV-2 genetic variation in immunocompromised patients: a retrospective case-control study

49. Heart and systemic sclerosis—findings from a national cohort study

Catalog

Books, media, physical & digital resources